Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromosome end protection by RAP1-mediated inhibition of DNA-PK. | Nature | 2025 | 40240611 | PubTator, text mining | PubMed |
| The linker region of a development-specific DNA polymerase X ensures efficient repair of programmed DNA double-strand breaks in Parameciumtetraurelia. | Nucleic Acids Res | 2025 | 40239989 | PubTator, text mining | PubMed |
| Direct preparation of Cas9 ribonucleoproteins with an extended 'gRNA-shRNA' construct in Escherichia coli for precise genome manipulation. | Int J Biol Macromol | 2025 | 40228775 | PubTator, text mining | PubMed |
| XRCC4-related microcephalic primordial dwarfism: description of a clinical series of 7 cases, phenotype expansion and new diagnostic approaches. | Eur J Hum Genet | 2025 | 40114033 | PubTator, text mining | PubMed |
| Case Report: Hypomorphic Ligase 4 deficiency - a paradigm of immunodysregulation. | Front Immunol | 2025 | 40093007 | PubTator, text mining | PubMed |
| Armadillo domain of ARID1A directly interacts with DNA-PKcs to couple chromatin remodeling with nonhomologous end joining (NHEJ) pathway. | Nucleic Acids Res | 2025 | 40087883 | PubTator, text mining | PubMed |
| Fibroblast-based radiosensitivity assays as a clinically valuable tool for (severe) combined immunodeficiency syndromes. | Mutat Res Genet Toxicol Environ Mutagen | 2025 | 40044379 | PubTator, text mining | PubMed |
| DNA Ligase 4 Inhibition Sensitizes Prostate Cancer to Immune Checkpoint Blockade In Vivo. | Anticancer Res | 2025 | 40037856 | PubTator, text mining | PubMed |
| BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance. | bioRxiv | 2025 | 40027615 | PubTator, text mining | PubMed |
| Prime Editing: Mechanistic Insights and DNA Repair Modulation. | Cells | 2025 | 39996750 | PubTator, text mining | PubMed |
| Ku suppresses RNA-mediated innate immune responses in human cells to accommodate primate-specific Alu expansion. | bioRxiv | 2025 | 39975384 | PubTator, text mining | PubMed |
| DNA ligase IV deficiency identified in a patient with hypergonadotropic hypogonadism: a case report. | J Pediatr Endocrinol Metab | 2025 | 39953892 | PubTator, text mining | PubMed |
| Repeat expansion in a fragile X model is independent of double strand break repair mediated by Pol θ, RAD52, RAD54 or RAD54B. | Sci Rep | 2025 | 39934227 | PubTator, text mining | PubMed |
| The Ataxia-telangiectasia mutated (ATM) is the most important gene for repairing the DNA in Myelodysplastic Neoplasm. | DNA Repair (Amst) | 2025 | 39874624 | PubTator, text mining | PubMed |
| Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage. | Nat Cell Biol | 2025 | 39805921 | PubTator, text mining | PubMed |
| Preimplantation genetic testing for four families with severe combined immunodeficiency: Three unaffected livebirths. | Orphanet J Rare Dis | 2025 | 39789600 | PubTator, text mining | PubMed |
| IL-6 Exacerbates Oxidative Damage of RPE Cells by Indirectly Destabilizing the mRNA of DNA Repair Genes. | Inflammation | 2025 | 39581910 | PubTator, text mining | PubMed |
| High yield of monogenic short stature in children from Kurdistan, Iraq: A genetic testing algorithm for consanguineous families. | Genet Med | 2025 | 39580647 | PubTator, text mining | PubMed |
| EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair. | Oncogene | 2025 | 39562655 | PubTator, text mining | PubMed |
| SelectRepair Knockout: Efficient PTC-Free Gene Knockout Through Selectable Homology-Directed DNA Repair. | Methods Mol Biol | 2025 | 39535722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=4